About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Philadelphia | 189 Studies

Clinical Trials COPDPhiladelphia

COPD Clinical Trials in Philadelphia

Find 189 clinical trials for copd near Philadelphia, Pennsylvania. Connect with research centers in your area.

All COPD trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 189 trials

CompletedAn Observational Study of Beta-Blocker Use in Patients With COPD and Acute MIThe study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to…NCT04717492·Birmingham, Alabama and 23 others Completed1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)This study was designed to investigate the 1 year efficacy and safety of the 50 µg once daily (od) dose of glycopyrronium bromide (NVA237) in patients with moderate to severe…NCT00929110·Birmingham, Alabama and 138 others

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have…NCT05878769·Birmingham, Alabama and 480 others

CompletedMacrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to determine if long-term administration of a macrolide antibiotic will reduce worsening of symptoms among individuals with chronic obstructive…NCT00325897·Birmingham, Alabama and 9 others

CompletedEffects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalizationBackground: COPD exacerbations add considerably to patients' burden because they: (1) cause frequent hospital admissions and relapses or readmissions, (2) contribute directly to…NCT01973998·Philadelphia, Pennsylvania

CompletedUS Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyThe purpose of this study it to evaluate the efficacy and safety of the 20 mL BLVR System in patients with advanced upper lobe predominant emphysema.NCT00515164·Phoenix, Arizona and 7 others

CompletedInvestigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for ExacerbationsThe aim of this First Time in Patient study is to obtain initial information on the safety, tolerability, pharmacokinetics, pharmacodynamics and clinical efficacy of repeat daily…NCT02130193·Birmingham, Alabama and 15 others

CompletedLung Tissue Research ConsortiumThe LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to…NCT02988388·Ann Arbor, Michigan and 3 others

CompletedLong-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).Subjects who completed either OBERON or TITANIA will be offered the opportunity to consent for this Multicentre, Double-blind, Randomised, Placebo controlled, Parallel Group…NCT05742802·Sheffield, Alabama and 334 others

CompletedEfficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryThe purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in symptomatic patients with moderate to very severe COPD who are receiving standard of…NCT02155660·Birmingham, Alabama and 355 others

TerminatedPilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With EmphysemaPhase 2a multicenter, randomized, double-blind, placebo-controlled study to assess the pharmacodynamics, efficacy, and safety of tetomilast in patients with emphysema.NCT00874497·Birmingham, Alabama and 14 others

CompletedEvaluation of the Spiration® Valve System for Emphysema to Improve Lung FunctionEMPROVE is a multicenter, prospective, randomized, controlled study designed to evaluate the safety and long-term effectiveness of the Spiration Valve System in patients with…NCT01812447·Fort Smith, Arkansas and 33 others

CompletedNursing-Driven Primary Palliative Care for Urban-Dwelling African Americans With Chronic Lung DiseaseIn prior work, this research team developed a telehealth primary care model (TIPC), designed in close partnership with patients and clinicians to address a widespread increase in…NCT05611125·Philadelphia, Pennsylvania

TerminatedBenefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD) affects over 14 million people in the United States.NCT00325754·Birmingham, Alabama and 9 others

CompletedSafety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) SubjectsThis is a multi-center study to evaluate the long-term safety of arformoterol 15 mcg twice daily (BID) in the treatment of subjects with moderate-to-severe COPD.NCT00909779·Birmingham, Alabama and 72 others

CompletedAn Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.The primary objective of this study is to compare the bronchodilator efficacy of three doses (50 µg, 100 µg and 200 µg) of BEA 2180 delivered by the Respimat® once daily to…NCT00528996·Jasper, Alabama and 177 others

Active not recruitingA Study to Evaluate Solrikitug in Participants With COPD (ZION)A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in…NCT06496620·Birmingham, Alabama and 109 others

TerminatedA 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.NCT04636814·Andalusia, Alabama and 459 others

CompletedSurvival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.NCT00268216·Birmingham, Alabama and 458 others

CompletedTiotropium / Respimat One Year Study in COPD.The objective of the study is to evaluate the long-term (one year) efficacy and safety of tiotropium delivered by the Respimat inhaler in patients with COPD.NCT00387088·Birmingham, Alabama and 333 others

PreviousPage 2 of 10Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia